About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 San Antonio Breast Cancer Symposium
2019 ASH Annual Meeting & Exposition
ESMO Immuno-Oncology Congress 2019
2019 Lynn Sage Breast Cancer Symposium
Biomarkers in Immunotherapy
Methotrexate–Induced Kidney Injury
2016 Society of Gynecologic Oncology Annual Meeting
Today In Oncology
Society for Integrative Oncology’s 16th International Conference
Ovarian Tissue Cryopreservation to Preserve Fertility in Pediatric Patients With Cancer
Asciminib for Patients With CML After Failure of ABL Kinase Inhibitor Treatment
Screening Rates Rose Among People Age 45–49 After Release of Updated Colorectal Cancer Guidelines
Long-Term Results of IBIS-II
Most Read Stories
Management of HER2-Positive Breast Cancer: Business as Usual?
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Comparing Options for Ovarian Tissue Cryopreservation to Preserve Fertility in Pediatric Patients With Cancer
Does Adding Trastuzumab to Adjuvant Chemotherapy Improve Invasive Disease–Free Survival for Patients With HER2-Negative Breast Cancer?
Dietary Supplement Use During Adjuvant Chemotherapy and Treatment Outcomes in Patients With Early Breast Cancer
Most Viewed Videos
C. Ola Landgren, MD, PhD, on Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab for Newly Diagnosed Multiple Myeloma
Nitin Jain, MD, on First-Line Ibrutinib Plus Venetoclax in CLL
Nadine M. Tung, MD, on HER2-Negative Breast Cancer: INFORM Trial of Cisplatin vs Doxorubicin/Cyclophosphamide
Sara M. Tolaney, MD, MPH, on HER2-Positive Breast Cancer: ATEMPT Trial on T-DM1 vs Paclitaxel Plus Trastuzumab
Ariella B. Hanker, PhD, on Therapeutic Implications of HER2 and HER3 Mutations in Breast Cancer
© 2020 HSP News Service, L.L.C.